SCHEMBL30571125

SCHEMBL30571125

CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MAPK8 P45983 1/20 0.56
▸ MAPK9 P45984 1/20 0.56
▸ MAPK10 P53779 1/20 0.56
▸ EPHA2 P29317 2/20 0.55
▸ KEAP1 Q14145 2/20 0.53
▸ NTSR2 O95665 4/20 0.53
▸ NTSR1 P30989 4/20 0.53
▸ SORT1 Q99523 4/20 0.53
▸ EP300 Q09472 1/20 0.52
▸ HIF1A Q16665 1/20 0.52
▸ NPY2R P49146 7/20 0.51
▸ NPY4R P50391 7/20 0.51
▸ NPY5R Q15761 7/20 0.51
▸ NPY1R P25929 5/20 0.51
▸ CALCRL Q16602 1/20 0.51
▸ KDM1A O60341 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30571140 0.97 NPY2R (0.55) MAPK8MAPK9MAPK10EPHA2NTSR2
SCHEMBL30959073 0.89 MAPK8 (0.59) MAPK8MAPK9MAPK10EPHA2KEAP1
SCHEMBL29761735 0.88 MAPK8 (0.57) MAPK8MAPK9MAPK10NPY2RNPY4R
SCHEMBL29479811 0.88 NPY2R (0.62) MAPK8MAPK9MAPK10EP300HIF1A
SCHEMBL30522300 0.88 EPHA2 (0.62) MAPK8MAPK9MAPK10EPHA2NTSR2
SCHEMBL30571141 0.88 MAPK8 (0.59) MAPK8MAPK9MAPK10EPHA2NTSR2
SCHEMBL30422996 0.87 EP300 (0.60) MAPK8MAPK9MAPK10KEAP1EP300
SCHEMBL31182749 0.87 NPY2R (0.61) KEAP1NPY2RNPY4RNPY5RNPY1R
SCHEMBL31307292 0.87 CALCRL (0.56) MAPK8MAPK9MAPK10EPHA2KEAP1
SCHEMBL30880904 0.86 EPHA2 (0.59) EPHA2NTSR2NTSR1SORT1EP300

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230263881-A1 Vaccine compositions for SARS-related coronaviruses and methods of use ASCIONE RICHARD (US) 2023-08-24 — — US disclosed
Send feedback